 CAMBRIDGE, Mass., Dec. 1, 2020 PRNewswire -- Cogent Biosciences, Inc. Nasdaq: COGT, a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of an underwritten public offering of 10,256,411 shares of its common... 